We are live on ! Find out more
RC

RBF Capital Portfolio holdings

AUM $2.41B
1-Year Est. Return 39.41%
This Fund
S&P 500
This Quarter Est. Return
-16.46%
1 Year Est. Return
+39.41%
3 Year Est. Return
+146.98%
5 Year Est. Return
+207.22%
10 Year Est. Return
+1,174.87%
AUM
$1.44B
AUM Growth
-$126M
Cap. Flow
+$1.85M
Cap. Flow %
0.13%
Top 10 Hldgs %
26.11%
Holding
561
New
43
Increased
41
Reduced
67
Closed
36

Top Buys

Rank Stock Value
1
UBER icon
Uber
UBER
+$12.9M
2
WLFC icon
Willis Lease Finance
WLFC
+$2.77M
3
BCS icon
Barclays
BCS
+$2.75M
4
BGC icon
BGC Group
BGC
+$2.58M
5
JD icon
JD.com
JD
+$1.9M

Sector Composition

Rank Sector Weight
1 Financials 26.06%
2 Industrials 13.73%
3 Consumer Discretionary 11.76%
4 Technology 11.67%
5 Miscellaneous 7.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FNHC
501
DELISTED
FedNat Holding Company Common Stock
FNHC
$93K 0.01%
300,000
-173,843
-37% -$95K
DHC
502
Diversified Healthcare Trust
DHC
$1.85B
$91K 0.01%
50,000
AP.WS
503
DELISTED
Ampco-Pittsburgh Corp Series A Warrants
AP.WS
$88K 0.01%
211,652
IVC
504
DELISTED
Invacare Corporation
IVC
$75K 0.01%
58,453
-41,547
-42% -$54.7K
SALM
505
DELISTED
Salem Media Group, Inc. Class A Common Stock
SALM
$73K 0.01%
34,200
AKUS
506
DELISTED
Akouos Inc
AKUS
$72K 0.01%
+15,290
New +$54K
QMCO icon
507
Quantum Corp
QMCO
$877M
$68K ﹤0.01%
1,500
TUYA
508
Tuya Inc
TUYA
$1.15B
$65K ﹤0.01%
24,800
MCHX icon
509
Marchex
MCHX
$81.6M
$55K ﹤0.01%
41,600
STTK icon
510
Shattuck Labs
STTK
$707M
$53K ﹤0.01%
+13,000
New +$47.1K
ALLT icon
511
Allot
ALLT
$381M
$51K ﹤0.01%
10,360
TSHA icon
512
Taysha Gene Therapies
TSHA
$1.88B
$51K ﹤0.01%
+13,800
New +$54.7K
CASI
513
DELISTED
CASI Pharmaceuticals
CASI
$46K ﹤0.01%
15,936
-1
-0% -$4
RGS icon
514
Regis Corp
RGS
$67.8M
$44K ﹤0.01%
2,020
CANG
515
Cango Inc
CANG
$91.5M
$41K ﹤0.01%
1,826
OKUR
516
OnKure Therapeutics
OKUR
$153M
$39K ﹤0.01%
+1,454
New +$33.8K
EVOL
517
DELISTED
Evolving Systems, Inc.
EVOL
$37K ﹤0.01%
24,496
ASMB icon
518
Assembly Biosciences
ASMB
$694M
$31K ﹤0.01%
1,228
XLO icon
519
Xilio Therapeutics
XLO
$59.2M
$29K ﹤0.01%
+719
New +$38K
FBIO icon
520
Fortress Biotech
FBIO
$92.4M
$25K ﹤0.01%
+2,000
New +$29.6K
WLMS
521
DELISTED
Williams Industrial Services Group Inc.
WLMS
$19K ﹤0.01%
14,000
ENG
522
DELISTED
ENGlobal Corp
ENG
$18K ﹤0.01%
2,364
VINC
523
DELISTED
Vincerx Pharma, Inc. Common Stock
VINC
$15K ﹤0.01%
+583
New +$25.9K
AMC icon
524
CALL
AMC Entertainment Holdings
AMC
$2.31B
-2,900
Closed -$715K
AMZN icon
525
PUT
Amazon
AMZN
$2.87T
-20,000
Closed -$3.26M

Similar funds

RBF Capital's Q2 2022 Portfolio in Review

As of Q2 2022, RBF Capital held 561 positions worth $1.44B, down 8.1% from $1.56B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

RBF Capital's Q2 2022 filing shows 43 new, 41 increased, 67 reduced and 36 closed positions. Its largest new stake was BGC Group: 741,777 shares worth $2.5M. The largest sale was iPath Series B S&P 500 VIX Short-Term Futures ETN, an estimated $6.93M.

By sector, the portfolio is most concentrated in Financials at 26% of assets, up from 25% a quarter earlier, followed by Industrials and Consumer Discretionary.

  • RBF Capital's largest Q2 2022 buy was BGC Group: 741,777 shares worth $2.5M.
  • RBF Capital added most to Uber in Q2 2022, an estimated $12.9M increase.
  • RBF Capital's biggest Q2 2022 reduction was iPath Series B S&P 500 VIX Short-Term Futures ETN, cutting an estimated $6.93M.
  • RBF Capital fully exited Huttig Building Products, Inc. in Q2 2022, selling an estimated $5.08M.
  • RBF Capital's ten largest holdings make up 26% of its $1.44B portfolio in Q2 2022.
  • RBF Capital opened 43 new positions and closed 36 in Q2 2022.
  • RBF Capital's portfolio value fell 8.1% quarter-over-quarter to $1.44B.

Based on RBF Capital's 13F filing for Q2 2022, filed 15 Aug 2022.